Medical News
First Immunotherapy Drug Approval in Europe for Patients with Oesophageal Squamous Cell Carcinoma
Discover this promising news as it is the first treatment of its kind for these patients
...
New EMA Immunotherapy Drug Approval Broadens Treatment Options for Some Liver Cancer Patients
New treatment for patients with unresectable hepatocellular carcinoma now approved
...
Gastric Cancer Awareness Month – More About Gastric Cancer with a Patient Perspective
Discover more about gastric/stomach cancer
...Study Shows Blood Test Promising for Targeting of Some Cancer Treatments – DiCE Lends its Voice
Discover this promising advance for stomach and oesophageal cancer patients
...
DiCE Publishes in ESMO Open on mCRC Patient Journey in Eastern Europe
Discover the publication on mCRC in Eastern Europe with lead author Zorana Maravic
...
DiCE Collaboration with European Alliance for Personalised Medicine Bears Fruit
Discover an open access policy paper on biomarkers in oncology – a part of a collaborative effort
...DiCE Survey Results for Metastatic Colorectal Cancer Demonstrate Several Areas for Improvement
Find the results of our patient survey on metastatic colorectal cancer giving muscle to our arguments!
...
World Leading Oncologist Prof. Van Cutsem Shares the Latest on Clinical Advances in Digestive Cancers
Access the latest news from world congresses with the renowned Professor – also DiCE Medical Director
...
About Digestive Cancers and the Coronavirus
The coronavirus (COVID-19) was officially declared a pandemic by the World Health Organisation (WHO) in March 2020. DiCE would like to share the fo...
Assessment of Duration and Effects of 3 vs 6 Months of Adjuvant Chemotherapy in High-Risk Stage II Colorectal Cancer
A journal article entitled ‘Assessment of Duration and Effects of 3 vs 6 Months of Adjuvant Chemotherapy in High-Risk Stage II Colorectal Can...
